Metabolism alteration in follicular niche: The nexus among intermediary metabolism, mitochondrial function, and classic polycystic ovary syndrome

Free Radic Biol Med. 2015 Sep:86:295-307. doi: 10.1016/j.freeradbiomed.2015.05.013. Epub 2015 Jun 6.

Abstract

Classic polycystic ovary syndrome (PCOS) is a high-risk phenotype accompanied by increased risks of reproductive and metabolic abnormalities; however, the local metabolism characteristics of the ovaries and their effects on germ cell development are unclear. The present study used targeted metabolomics to detect alterations in the intermediate metabolites of follicular fluid from classic PCOS patients, and the results indicated that hyperandrogenism but not obesity induced the changed intermediate metabolites in classic PCOS patients. Regarding the direct contact, we identified mitochondrial function, redox potential, and oxidative stress in cumulus cells which were necessary to support oocyte growth before fertilization, and suggested dysfunction of mitochondria, imbalanced redox potential, and increased oxidative stress in cumulus cells of classic PCOS patients. Follicular fluid intermediary metabolic profiles provide signatures of classic PCOS ovary local metabolism and establish a close link with mitochondria dysfunction of cumulus cells, highlighting the role of metabolic signal and mitochondrial cross talk involved in the pathogenesis of classic PCOS.

Keywords: Cumulus cells; Follicle fluid; Metabolism; Polycystic ovary syndrome; Pregnant outcome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amino Acids, Branched-Chain / metabolism
  • Carnitine / analogs & derivatives
  • Carnitine / metabolism
  • Case-Control Studies
  • Female
  • Glycolysis
  • Humans
  • Ketone Bodies
  • Mitochondria / metabolism*
  • Mitophagy
  • Organelle Biogenesis
  • Ovarian Follicle / metabolism*
  • Ovarian Follicle / pathology
  • Oxidation-Reduction
  • Oxidative Stress
  • Polycystic Ovary Syndrome / metabolism*
  • Polycystic Ovary Syndrome / pathology
  • Polycystic Ovary Syndrome / therapy
  • Pregnancy
  • Pregnancy Rate
  • Reproductive Techniques, Assisted
  • Treatment Outcome

Substances

  • Amino Acids, Branched-Chain
  • Ketone Bodies
  • acylcarnitine
  • Carnitine